Lithium Carbonate Capsule, Gelatin Coated
NDC Package 72789-173-01
Package Information
Lithium Carbonate capsules is lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder:Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14)] Maintenance treatment in patients 7 years and older [see Clinical Studies ( 14)]. This formulation utilizes a capsule, gelatin coated delivery system. Marketed by Pd-rx Pharmaceuticals, Inc., this product is identified by NDC 72789-173 and is authorized under FDA application NDA017812.
Identification & Billing
- RxCUI: 197889 - lithium carbonate 300 MG Oral Capsule
- RxCUI: 197889 - LiCO3 300 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72789 - Pd-rx Pharmaceuticals, Inc.
- 72789-173 - Lithium Carbonate
- 72789-173-01 - 100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC
- 72789-173 - Lithium Carbonate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72789-173-01 identifies a specific commercial package of 100 capsule, gelatin coated in 1 bottle, plastic of Lithium Carbonate, a human prescription drug labeled by Pd-rx Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This capsule, gelatin coated is formulated for oral use and contains lithium carbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pd-rx Pharmaceuticals, Inc. on November 26, 1980. The current certification is valid through December 31, 2027.
How is this Pd-rx Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72789017301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.